The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 08, 2021
Filed:
Oct. 01, 2018
Applicants:
Deutsches Krebsforschungszentrum, Heidelberg, DE;
Ruprecht-karls-universitat Heidelberg, Heidelberg, DE;
Inventors:
Barbara Leuchs, Heidelberg, DE;
Antonio Marchini, Heidelberg, DE;
Jean Rommelaere, Heidelberg, DE;
Assia Angelova, Heidelberg, DE;
Dirk Jager, Mainz-Kostheim, DE;
Wolfgang Wick, Heidelberg, DE;
Michael Dahm, Munich, DE;
Assignees:
DEUTSCHES KREBSFORSCHUNGSZENTRUM, Heidelberg, DE;
RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG, Heidelberg, DE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39541 (2013.01); A61K 35/768 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C12N 2750/14332 (2013.01);
Abstract
The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer.